GB202204070D0 - Treatment - Google Patents
TreatmentInfo
- Publication number
- GB202204070D0 GB202204070D0 GBGB2204070.3A GB202204070A GB202204070D0 GB 202204070 D0 GB202204070 D0 GB 202204070D0 GB 202204070 A GB202204070 A GB 202204070A GB 202204070 D0 GB202204070 D0 GB 202204070D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2204070.3A GB202204070D0 (en) | 2022-03-23 | 2022-03-23 | Treatment |
PCT/EP2023/057432 WO2023180431A1 (en) | 2022-03-23 | 2023-03-23 | Imatinib for use in the treatment of acute respiratory distress syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2204070.3A GB202204070D0 (en) | 2022-03-23 | 2022-03-23 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202204070D0 true GB202204070D0 (en) | 2022-05-04 |
Family
ID=81344807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2204070.3A Ceased GB202204070D0 (en) | 2022-03-23 | 2022-03-23 | Treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202204070D0 (en) |
WO (1) | WO2023180431A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2717883T3 (en) | 2011-05-02 | 2017-04-24 | Stichting Vumc | PROTECTION AGAINST ENDOTELIAL BARRIER DYSFUNCTION BY INHIBITION OF THE TYROSINKINASE ABL RELATED GENES (ARG) |
-
2022
- 2022-03-23 GB GBGB2204070.3A patent/GB202204070D0/en not_active Ceased
-
2023
- 2023-03-23 WO PCT/EP2023/057432 patent/WO2023180431A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023180431A1 (en) | 2023-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202319954D0 (en) | Treatment | |
GB202319658D0 (en) | Treatment | |
GB202319443D0 (en) | Treatment | |
GB202318845D0 (en) | Treatment | |
GB202311007D0 (en) | Treatment | |
GB202304853D0 (en) | Treatment | |
GB202218460D0 (en) | Treatment | |
GB202214206D0 (en) | Treatment | |
GB202212125D0 (en) | Treatment | |
GB202204288D0 (en) | Treatment | |
GB202204070D0 (en) | Treatment | |
GB202201069D0 (en) | Treatment | |
GB202212566D0 (en) | Combination treatment | |
GB202304716D0 (en) | New treatment | |
GB202210430D0 (en) | New treatment | |
GB202206219D0 (en) | New treatment | |
GB202208508D0 (en) | Novel treatment | |
GB202109812D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |